Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-22-008569
Filing Date
2022-08-11
Accepted
2022-08-11 17:30:05
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27663
2 filename2.txt TEXT-EXTRACT 1503
  Complete submission text file 0000000000-22-008569.txt   40237
Mailing Address 128 SPRING STREET BUILDING A, SUITE 510 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING A, SUITE 510 LEXINGTON MA 02421 857-285-4140
Cyteir Therapeutics, Inc. (Filed for) CIK: 0001662244 (see all company filings)

EIN.: 455429901 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations